Trial Profile
Comparison of Alogliptin Versus Alogliptin and Pioglitazone on Insulin Resistance and Beta Cell Function of Metformin Treated Women With Polycystic Ovary Syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Alogliptin/metformin (Primary) ; Alogliptin/pioglitazone (Primary)
- Indications Insulin resistance; Polycystic ovary syndrome
- Focus Therapeutic Use
- 23 Feb 2016 New trial record